To include your compound in the COVID-19 Resource Center, submit it here.

TZP-102: Additional Phase II data

Additional data from a double-blind, international Phase II trial in 92 Type I or II diabetics with gastroparesis showed that

Read the full 208 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE